Advertisement

In Vitro Cellular & Developmental Biology - Animal

, Volume 52, Issue 8, pp 857–863 | Cite as

Berberine modulates cisplatin sensitivity of human gastric cancer cells by upregulation of miR-203

  • He-Yi You
  • Xue-Meng Xie
  • Wei-Jian Zhang
  • Heng-Liang Zhu
  • Fei-Zhao Jiang
Article

Abstract

Chemotherapeutic resistance is the main reason of the failure in clinical treatment of gastric cancer. Berberine (BER) is the active compound of traditional Chinese medicine Huang Lian. The aim of this present study is to evaluate the effect of BER on cisplatin resistance in gastric cancer cells and to investigate its possible mechanism. Gastric cancer cell lines SGC-7901 and BGC-823 and their respective cisplatin-resistant variants SGC-7901/DDP and BGC-823/DDP were used in this study. We found that BER treatment significantly reversed cisplatin sensitivity and induced caspase-dependent apoptosis in SGC-7901/DDP and BGC-823/DDP cells; BER treatment induced miR-203 expression, and overexpression of miR-203 mimicked the cisplatin-sensitizing effect of BER. Importantly, we showed that miR-203 was able to target the 3′UTR of Bcl-w. Therefore, we conclude that BER treatment reduces cisplatin resistance of gastric cancer cells by modulating the miR-203/Bcl-w apoptotic axis. BER may be a novel agent to enhance chemotherapeutic responses in cisplatin-resistant gastric cancer patients.

Keywords

Berberine MicroRNA-203 Apoptosis Bcl-w Gastric cancer 

References

  1. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297CrossRefPubMedGoogle Scholar
  2. Chang, W., Chen, L., and Hatch, G.M. (2014). Berberine as a therapy for type 2 diabetes and its complications: from mechanism of action to clinical studies. Biochem Cell Biol, 1–8.Google Scholar
  3. Chen Q, Qin R, Fang Y, Li H (2015) Berberine sensitizes human ovarian cancer cells to cisplatin through miR-93/PTEN/Akt signaling pathway. Cell Physiol Biochem 36:956–965CrossRefPubMedGoogle Scholar
  4. Chiang Y, Song Y, Wang Z, Chen Y, Yue Z, Xu H, Xing C, Liu Z (2011) Aberrant expression of miR-203 and its clinical significance in gastric and colorectal cancers. J Gastrointest Surg 15:63–70CrossRefPubMedGoogle Scholar
  5. Hu HY, Li KP, Wang XJ, Liu Y, Lu ZG, Dong RH, Guo HB, Zhang MX (2013) Set9, NF-kappaB, and microRNA-21 mediate berberine-induced apoptosis of human multiple myeloma cells. Acta Pharmacol Sin 34:157–166CrossRefPubMedGoogle Scholar
  6. Imaoka, H., Toiyama, Y., Okigami, M., Yasuda, H., Saigusa, S., Ohi, M., Tanaka, K., Inoue, Y., Mohri, Y., and Kusunoki, M. (2015). Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer. Gastric CancerGoogle Scholar
  7. Li XK, Motwani M, Tong W, Bornmann W, Schwartz GK (2000) Huanglian, a Chinese herbal extract, inhibits cell growth by suppressing the expression of cyclin B1 and inhibiting CDC2 kinase activity in human cancer cells. Mol Pharmacol 58:1287–1293PubMedGoogle Scholar
  8. Li DX, Zhang J, Zhang Y, Zhao PW, Yang LM (2015) Inhibitory effect of berberine on human skin squamous cell carcinoma A431 cells. Genet Mol Res 14:10553–10568CrossRefPubMedGoogle Scholar
  9. Lin JP, Yang JS, Lee JH, Hsieh WT, Chung JG (2006) Berberine induces cell cycle arrest and apoptosis in human gastric carcinoma SNU-5 cell line. World J Gastroenterol 12:21–28CrossRefPubMedPubMedCentralGoogle Scholar
  10. Lin JP, Yang JS, Wu CC, Lin SS, Hsieh WT, Lin ML, Yu FS, Yu CS, Chen GW, Chang YH et al (2008) Berberine induced down-regulation of matrix metalloproteinase-1, −2 and −9 in human gastric cancer cells (SNU-5) in vitro. In Vivo 22:223–230PubMedGoogle Scholar
  11. Liu S, Fang Y, Shen H, Xu W, Li H (2013) Berberine sensitizes ovarian cancer cells to cisplatin through miR-21/PDCD4 axis. Acta Biochim Biophys Sin Shanghai 45:756–762CrossRefPubMedGoogle Scholar
  12. McKenna DJ, McDade SS, Patel D, McCance DJ (2010) MicroRNA 203 expression in keratinocytes is dependent on regulation of p53 levels by E6. J Virol 84:10644–10652CrossRefPubMedPubMedCentralGoogle Scholar
  13. Ortiz LM, Lombardi P, Tillhon M, Scovassi AI (2014) Berberine, an epiphany against cancer. Molecules 19:12349–12367CrossRefPubMedGoogle Scholar
  14. Pandey A, Vishnoi K, Mahata S, Tripathi SC, Misra SP, Misra V, Mehrotra R, Dwivedi M, Bharti AC (2015) Berberine and curcumin target survivin and STAT3 in gastric cancer cells and synergize actions of standard chemotherapeutic 5-fluorouracil. Nutr Cancer 67:1293–1304CrossRefPubMedGoogle Scholar
  15. Pasquinelli AE (2012) MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet 13:271–282PubMedGoogle Scholar
  16. Shi, Y., Tan, Y.J., Zeng, D.Z., Qian, F., and Yu, P.W. (2015). miR-203 suppression in gastric carcinoma promotes Slug-mediated cancer metastasis. Tumour BiolGoogle Scholar
  17. Siddik ZH (2003) Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22:7265–7279CrossRefPubMedGoogle Scholar
  18. Tang J, Li L, Huang W, Sui C, Yang Y, Lin X, Hou G, Chen X, Fu J, Yuan S et al (2015) MiR-429 increases the metastatic capability of HCC via regulating classic Wnt pathway rather than epithelial-mesenchymal transition. Cancer Lett 364:33–43CrossRefPubMedGoogle Scholar
  19. Wan X, Ding X, Chen S, Song H, Jiang H, Fang Y, Li P, Guo J (2015) The functional sites of miRNAs and lncRNAs in gastric carcinogenesis. Tumour Biol 36:521–532CrossRefPubMedPubMedCentralGoogle Scholar
  20. Wang J, Peng Y, Liu Y, Yang J, Ding N, Tan W (2015a) Berberine, a natural compound, suppresses Hedgehog signaling pathway activity and cancer growth. BMC Cancer 15:595CrossRefPubMedPubMedCentralGoogle Scholar
  21. Wang N, Tan HY, Li L, Yuen MF, Feng Y (2015b) Berberine and Coptidis Rhizoma as potential anticancer agents: recent updates and future perspectives. J Ethnopharmacol 176:35–48CrossRefPubMedGoogle Scholar
  22. Wang N, Zhu M, Tsao SW, Man K, Zhang Z, Feng Y (2013) MiR-23a-mediated inhibition of topoisomerase 1 expression potentiates cell response to etoposide in human hepatocellular carcinoma. Mol Cancer 12:119CrossRefPubMedPubMedCentralGoogle Scholar
  23. Wang N, Zhu M, Wang X, Tan HY, Tsao SW, Feng Y (2014) Berberine-induced tumor suppressor p53 up-regulation gets involved in the regulatory network of MIR-23a in hepatocellular carcinoma. Biochim Biophys Acta 1839:849–857CrossRefPubMedGoogle Scholar
  24. Yi T, Zhuang L, Song G, Zhang B, Li G, Hu T (2015) Akt signaling is associated with the berberine-induced apoptosis of human gastric cancer cells. Nutr Cancer 67:523–531CrossRefPubMedGoogle Scholar
  25. Yu YN, Yu TC, Zhao HJ, Sun TT, Chen HM, Chen HY, An HF, Weng YR, Yu J, Li M et al (2015) Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment. Oncotarget 6:32013–32026PubMedPubMedCentralGoogle Scholar
  26. Zhang X, Zhang Y, Liu X, Fang A, Li P, Li Z, Liu T, Yang Y, Du L, Wang C (2015) MicroRNA-203 is a prognostic indicator in bladder cancer and enhances chemosensitivity to cisplatin via apoptosis by targeting Bcl-w and survivin. PLoS ONE 10, e0143441CrossRefPubMedPubMedCentralGoogle Scholar
  27. Zhou X, Xu G, Yin C, Jin W, Zhang G (2014) Down-regulation of miR-203 induced by Helicobacter pylori infection promotes the proliferation and invasion of gastric cancer by targeting CASK. Oncotarget 5:11631–11640CrossRefPubMedPubMedCentralGoogle Scholar
  28. Zhu T, Li LL, Xiao GF, Luo QZ, Liu QZ, Yao KT, Xiao GH (2015) Berberine increases doxorubicin sensitivity by suppressing STAT3 in lung cancer. Am J Chin Med 43:1487–1502CrossRefPubMedGoogle Scholar

Copyright information

© The Society for In Vitro Biology 2016

Authors and Affiliations

  • He-Yi You
    • 1
  • Xue-Meng Xie
    • 1
  • Wei-Jian Zhang
    • 1
  • Heng-Liang Zhu
    • 1
  • Fei-Zhao Jiang
    • 1
  1. 1.Department of Laparoscopic SurgeryThe First Affiliated Hospital of Wenzhou Medical UniversityWenzhouChina

Personalised recommendations